For the past few months, Life Technologies Corporation (LIFE
), the global biotechnology company that makes DNA-sequencing equipment, laboratory instruments and lab testing products, is still in discussions with potential buyers. The company has over 50,0000 products and 5,000 patents used in cellular testing and research, forensics, food and water safety, animal health, clinical testing and numerous other applications in research science, applied science, and medical science. In its gene-sequencing sector, Life Technologies Corp. competes with Illumina Inc. (ILMN
). Both California-based companies use technology that can “blueprint” a human being’s DNA for medical purposes in the emerging field of molecular diagnostics.
As potential sale details unfold, Life Technologies continues to make significant advances in stem cell research and molecular diagnostics. Earlier this month, Life Technologies signed a collaborative stem cell products research agreement with Harvard University. In another win last week, the company received an FDA clearance to market a molecular diagnostic assay made by the Quidel Corporation, for use with Life Technologies’ equipment and software. The test is helpful to at-risk elderly patients with respiratory infections. Continue Reading »